Pandemblock Oy
3242819-1ActiveDeveloping preventive intranasal antivirals targeting respiratory viruses globally.
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 2021
- Grunnlagt
Nøkkelbeslutningstakere
Pasi Kemppainen
Business Development and Partner Relations, Founder
Kalle Saksela
Scientific Advisor
Anna R. Mäkelä
CEO and Founder
Beskrivelse
Pandemblock Ltd is a biotechnology company spun out from the University of Helsinki in the fall of 2021. The organization is dedicated to developing innovative, affordable antiviral intranasal inhibitors aimed at improving pandemic preparedness and control. Their core technology is the proprietary S...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- 16
- MVA-nummer
- FI32428191
Beslutningstakere
3 kontakter i FunnelfeedrPasi Kemppainen
Business Development and Partner Relations, Founder
Kalle Saksela
Scientific Advisor
Anna R. Mäkelä
CEO and Founder
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Virenc Holding AB
Developing novel peptide therapeutics against enveloped viruses for global health.
ROKOTE LABORATORIES FINLAND OY
Developing universal intranasal vaccines to block respiratory virus infection effectively.
1928 Diagnostics AB
5 ansatteDelivering fast bioinformatics solutions to fight antimicrobial resistance effectively.
Gedea Biotech AB
5–9 ansatteSwedish biotech developing antibiotic-free BV treatment pHyph.
QureTech Bio AB
5–9 ansatteDeveloping novel synthetic antibiotics to combat drug-resistant bacteria.
Utforsk mer
Spørsmål om Pandemblock Oy
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo